Education
About Us
Working with TipRanks
Follow Us
Apogee Therapeutics (APGE)
NASDAQ:APGE
APGE Analyst Ratings
Strong Buy
13 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
APGE Stock 12 Month Forecast
Average Price Target
$102.50
▲(32.29% Upside)
| Highest Price Target$137.00 | Average Price Target$102.50 | Lowest Price Target$70.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Wolfe Research
Hold
―
Initiated
01/07/26
Mizuho Securities
$105
Buy
35.52%
Upside
Reiterated
01/07/26
Craig-Hallum
$109→$116
Buy
49.72%
Upside
Reiterated
01/07/26
BTIG
$115→$137
Buy
76.82%
Upside
Reiterated
01/06/26
Stifel Nicolaus
$95→$133
Buy
71.66%
Upside
Reiterated
01/06/26
Canaccord Genuity
$89
Buy
14.87%
Upside
Reiterated
01/06/26
Bank of America Securities
$81→$84
Buy
8.42%
Upside
Reiterated
01/06/26
Citi
$95
Buy
22.61%
Upside
Reiterated
01/05/26
Stephens
$95
Buy
22.61%
Upside
Initiated
12/17/25
Deutsche Bank
$103
Buy
32.94%
Upside
Initiated
12/10/25
TD Cowen
Buy
―
Reiterated
12/03/25
RBC Capital
$70
Buy
-9.65%
Downside
Reiterated
11/10/25
Jefferies
$88→$96
Buy
23.90%
Upside
Reiterated
07/08/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Wolfe Research
Hold
―
Initiated
01/07/26
Mizuho Securities
$105
Buy
35.52%
Upside
Reiterated
01/07/26
Craig-Hallum
$109→$116
Buy
49.72%
Upside
Reiterated
01/07/26
BTIG
$115→$137
Buy
76.82%
Upside
Reiterated
01/06/26
Stifel Nicolaus
$95→$133
Buy
71.66%
Upside
Reiterated
01/06/26
Canaccord Genuity
$89
Buy
14.87%
Upside
Reiterated
01/06/26
Bank of America Securities
$81→$84
Buy
8.42%
Upside
Reiterated
01/06/26
Citi
$95
Buy
22.61%
Upside
Reiterated
01/05/26
Stephens
$95
Buy
22.61%
Upside
Initiated
12/17/25
Deutsche Bank
$103
Buy
32.94%
Upside
Initiated
12/10/25
TD Cowen
Buy
―
Reiterated
12/03/25
RBC Capital
$70
Buy
-9.65%
Downside
Reiterated
11/10/25
Jefferies
$88→$96
Buy
23.90%
Upside
Reiterated
07/08/25
Best Analysts Covering Apogee Therapeutics
1 Month
xxx
Success Rate
6/9 ratings generated profit
Average Return
+8.53%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +8.53% per trade.
3 Months
xxx
Success Rate
5/8 ratings generated profit
Average Return
+21.80%
reiterated a xxx
rating 6 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.50% of your transactions generating a profit, with an average return of +21.80% per trade.
1 Year
Success Rate
8/9 ratings generated profit
Average Return
+72.72%
reiterated a buy rating 5 days ago
Copying Edward Nash's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +72.72% per trade.
2 Years
xxx
Success Rate
6/6 ratings generated profit
Average Return
+94.07%
reiterated a xxx
rating 6 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +94.07% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
APGE Analyst Recommendation Trends
Rating
Sep 25
Oct 25
Nov 25
Dec 25
Jan 26
Strong Buy
15
10
11
11
8
Buy
3
3
6
10
15
Hold
0
0
0
1
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
18
13
17
22
26
Each month's total comprises the sum of three months' worth of ratings.
APGE Financial Forecast
APGE Stock Forecast FAQ
What is APGE’s average 12-month price target, according to analysts?
Based on analyst ratings, Apogee Therapeutics’s 12-month average price target is 102.50.
What is APGE’s upside potential, based on the analysts’ average price target?
Apogee Therapeutics has 32.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is APGE a Buy, Sell or Hold?
Apogee Therapeutics has a consensus rating of Strong Buy which is based on 13 buy ratings, 1 hold ratings and 0 sell ratings.
What is Apogee Therapeutics’s price target?
The average price target for Apogee Therapeutics is 102.50. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $137.00 ,the lowest forecast is $70.00. The average price target represents 32.29% Increase from the current price of $77.48.
The highest analyst price target is $137.00 ,the lowest forecast is $70.00. The average price target represents 32.29% Increase from the current price of $77.48.
What do analysts say about Apogee Therapeutics?
Apogee Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of APGE?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.